Resilience was founded in 2020 by Drew Oetting, Patrick Yang, Sandesh Mahatme, and Rahul Singhvi. Resilience has not officially endorsed a plan to participate in an IPO.
Resilience is a biotechnology company with a mission to streamline manufacturing processes for complex medicines. Per Forge data, Resilience raised $2.5 billion in funding over 7 rounds. Their latest funding was raised on Mar 24, 2023. Key investors include ARCH Venture Partners, 8VC, Mubadala, Magnetic Ventures, and the U.S. Department of Defense.
These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/06/2022 | Series D | $625MM | $xx.xx | $8.84B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
10,291,454
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
05/15/2021 | Series C | $600MM | $xx.xx | $5.81B | Strategic Innovation Fund, Applied Ventures, Raptor Group | |
Price per Share
$xx.xx
Shares Outstanding
13,510,471
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Strategic Innovation Fund, Applied Ventures, Raptor Group
|
||||||
11/23/2020 | Series B | $755MM | $xx.xx | $1.59B | ARCH Venture Partners, 8VC, New Enterprise Associates, Lux Capital, GV | |
Price per Share
$xx.xx
Shares Outstanding
55,270,864
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
ARCH Venture Partners, 8VC, New Enterprise Associates, Lux Capital, GV
|
||||||
04/17/2020 | Series A-2 | $9MM | $xx.xx | $147.02MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,991,142
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
04/17/2020 | Series A-1 | $45.28MM | $xx.xx | $147.02MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
22,088,402
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|